Merck, Schering-Plough In $41B Merger

by Jim Zarroli, NPR
March 9, 2009

The pharmaceutical giant Merck announced Monday it is acquiring rival Schering-Plough in a deal valued at $41 billion. Merck will pay a hefty premium for Schering in the cash and stock deal, which has already been approved by both boards.

Broadcast Dates

Latest News & Features


News Cut

with Bob Collins